Supplements > Understanding Total Cost of Care in Advanced Non-Small Cell Lung Cancer Pre- and Postapproval of Immuno-Oncology Therapies

Supplements - Understanding Total Cost of Care in Advanced Non-Small Cell Lung Cancer Pre- and Postapproval of Immuno-Oncology Therapies

October 19, 2018 – Beata Korytowsky, MA; Janna Radtchenko, MBA; Esmond D. Nwokeji, PhD; Kenneth W. Tuell, RPh, BCGP; Jonathan K. Kish, PhD, MPH; and Bruce A. Feinberg, DO
October 19, 2018
Copyright AJMC 2006-2018 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.